儿童急性淋巴细胞白血病死亡率:秘鲁和厄瓜多尔的区域分析
Katherine Simbaña-Rivera1,2,3, J Smith Torres-Roman4, Dante Julca-Marin3,5
1Center for Health Research in Latin America (CISeAL), Faculty of Medicine, Pontifical Catholic University of Ecuador (PUCE), Quito, Ecuador.
Asian Pacific journal of cancer prevention : APJCP
|August 24, 2025
概括
厄瓜多尔和秘鲁的儿童急性淋巴细胞白血病 (ALL) 死亡率从2005年到2020年显示出令人担忧的增加,特别是在秘鲁. 公共卫生策略对于儿童ALL的早期诊断和治疗至关重要.
科学领域:
- 儿童瘤学
- 流行病学
- 公共卫生
背景情况:
- 急性淋巴细胞白血病 (ALL) 是儿童瘤学的主要死亡原因.
- 关于拉丁美洲和加勒比地区儿童ALL的研究有限.
- 这项研究通过检查厄瓜多尔和秘鲁的ALL死亡率来解决数据短缺问题.
研究的目的:
- 确定2005年至2020年间厄瓜多尔和秘鲁的儿童ALL死亡率.
- 分析国家和性别的死亡率趋势.
- 发现死亡率的区域差异.
主要方法:
- 使用厄瓜多尔和秘鲁的死亡数据库.
- 每10万人/年计算的年龄标准化死亡率.
- 员工Joinpoint回归分析以评估2005年至2020年的死亡趋势.
主要成果:
- 在2016年至2020年期间,死亡率为每10万人中1.7 (男孩) 和1.2 (女孩).
- 沿海地区死亡率最高,雨林地区死亡率最低.
- 秘鲁的ALL死亡率显著增加,高地和利马的死亡率每年显著增加.
结论:
- 调查结果显示,秘鲁儿童ALL死亡率大幅上升.
- 建议立即实施早期诊断和治疗的公共卫生战略.
- 需要有针对性的干预措施来解决秘鲁儿童ALL死亡率的上升.
相关概念视频
02:41Lethal Alleles
15.7K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
15.7K
01:22Bone Marrow Sampling and Transplants
495
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
495